Skip to content
AVM-GSL Over the Counter Companion Animal

RSPCA WORMaway 50/144/150 mg Tablets for Dogs

Active ingredients: Febantel, Praziquantel, Pyrantel Embonate

Form

Tablet

Species

Dogs

Manufacturer

KRKA, d.d., Novo mesto

VMD MA No.

01656/5006

What it's used for

For the treatment of mixed infestations with the following roundworms and tapeworms in adult dogs and puppies: Nematodes Ascarids: , (late immature forms a...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Febantel + Praziquantel + Py...

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Clinical information

RSPCA WORMaway 50/144/150 mg Tablets for Dogs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

For the treatment of mixed infestations with the following roundworms and tapeworms
in adult dogs and puppies:
Nematodes
Ascarids: , (late immature forms and mature
forms)
Hookworms: , Ancylostoma caninum (adults)
Cestodes
Tapeworms: Dipylidium caninum
For oral administration.
It is important to follow the treatment recommendations as presented here. Do not
deviate from the recommendations without the advice of your veterinary surgeon.
Dosage
The recommended dose rates are: 15 mg/kg body weight febantel, 14.4 mg/kg pyrantel
and 5 mg/kg praziquantel. This is equivalent to 1 tablet per 10 kg body weight.
Tablets may be halved/quartered to allow accuracy of dosing.
Body weightTabletsOver 2 kg up to 2.5 kg¼ tabletOver 2.5 kg up to 5 kg½ tabletOver 5 kg up to 7.5 kg¾ tabletOver 7.5 kg up to 10 kg1 tabletOver 10 kg up to 15 kg1 ½ tabletsOver 15 kg up to 20 kg2 tabletsOver 20 kg up to 25 kg2 ½ tabletsOver 25 kg up to 30 kg3 tabletsOver 30 kg up to 35 kg3 ½ tabletsOver 35 kg up to 40 kg4 tablets
Administration and Duration of Treatment
The tablet(s) can be given directly to the dog or disguised in food. No restriction of
access to food is required either before or after administration of the product.
To ensure administration of a correct dose, body weight should be determined as
accurately as possible.

Revised: June 2023
AN: 02947/2022
Puppies may be wormed with this product from 2 weeks of age and every 2 weeks until
12 weeks of age. Thereafter they should be treated at 3 monthly intervals until 6
months of age. It is advisable to treat the bitch at the same time as the puppies.
For the control of , nursing bitches should be dosed 2 weeks after giving birth
and every 2 weeks until weaning.
For adult dogs, a single dose should be used. The advice of a veterinarian should be
sought regarding the need for and frequency of repeat treatment.
If signs of disease persist or appear, consult a veterinary surgeon.
Do not use simultaneously with piperazine compounds as piperazine may block the
action of pyrantel embonate contained in the product. Other worming products may
contain piperazine.
Do not use in bitches during the first two-thirds of pregnancy.

Revised: June 2023
AN: 02947/2022
Do not use in animals with a known hypersensitivity to the active substance or to any
of the excipients.
Do not use in dogs younger than 2 weeks of age and/or weighing less than 2 kg.
Do not use simultaneously with other deworming products without veterinary advice.
Dogs:
Very rare
(<1 animal / 10,000 animals
treated, including isolated
reports):
Loose faeces*, diarrhoea*, vomiting*, lethargy*,
loss of appetite*, hyperactivity*
*Transient.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or the national competent authority via the

Revised: June 2023
AN: 02947/2022
national reporting system. See also the last section of the package leaflet for contact
details.
Fleas serve as intermediate hosts for one common type of tapeworm –
caninum. Tapeworm infestation is certain to re-occur unless control of intermediate
hosts such as fleas, mice etc. is undertaken.
Dogs may become infected with worms by eating insects (including fleas and lice),
birds, small rodents, rabbits or raw offal from affected sheep, goats and cattle. Dogs
will continue to be re-infected unless the route of infection is controlled e.g. treating a
flea infestation or preventing a dog from scavenging or hunting.
Parasite resistance to any particular class of anthelmintic may develop following
frequent, repeated use of an anthelmintic of that class.

Special precautions for use in animals
Do not exceed the stated dose, especially when treating pregnant bitches.
In dogs less than 6 weeks old, tapeworm infections are highly uncommon. Treatment
of animals less than 6 weeks old with a fixed combination product against cestodes
and nematodes may, therefore, not be necessary.
To minimise the risk of reinfestation and new infestation, any excreta within 24 hours
following treatment should be collected and properly disposed of.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
In the interests of good hygiene, persons administering the tablet directly to a dog or
by adding it to the dog's food, should wash their hands afterwards.
In case of accidental ingestion, seek medical advice and show the package leaflet to
the physician.
Do not combine with piperazine as the anthelmintic effects of pyrantel and piperazine
(used in many worming products for dogs) may be antagonized.
Concurrent use with other cholinergic compounds can lead to toxicity.
Simultaneous administration of compounds that inhibit the activity of
acetylcholinesterase - AChE (e.g.organophosphates) may increase systemic effects
of pyrantel.
Plasma concentrations of praziquantel may be decreased by concomitant
administration with drugs that increase the activity of cytochrome P-450 enzymes
(e.g. dexamethasone, phenobarbital).
This medicinal product does not require any special storage conditions.
Not applicable.
5.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.